The treatment was already approved for pediatric upper limb spasticity earlier this year. This new approval was based on data from a phase 3 trial evaluating the safety and efficacy of Botox in 381 ...
Botulinum toxin type A was first used for the treatment of spasticity in 1989. A small uncontrolled study of treatment of upper limb spasticity after stroke reported encouraging benefits, including ...
- Revance now expects to report topline results from JUNIPER trial in early 2021 - NEWARK, Calif.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on ...
Correspondence to Daniel T Tarara, Department of Exercise Science, High Point University, School of Health Sciences, 833 Montlieu Avenue, High Point 27268, NC, USA; dtarara{at}highpoint.edu Objective ...
A review of instruments used to assess upper-limb function in patients with neuromuscular diseases found that more tools are needed to address specific diseases. In most neuromuscular diseases (NMDs), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results